PharmaMedic announces Virtual Breakfast Briefing on 10th February 2021 15 Dec 2020

PharmaMedic is delighted to announce the launch of a new series of virtual events starting with a breakfast briefing on Wednesday 10th February 2021 at 08:00 am.  The series is designed to brief executives in biopharma on hot topics that are shaping the future of the regulatory and medical affairs environment.

The first breakfast briefing will feature Dr Malcolm Barratt-Johnson, Dr Lucy Cook and Dr Zubair Hussain, who will discuss key trends in medical and regulatory affairs in the post-COVID landscape.  They will draw upon their decades of experience supporting biopharma and medical devices companies and their in-depth knowledge of the strategies and tactics that key players and emerging organisations alike are deploying in a new digital world.

The breakfast briefings are designed to offer a concise format for busy pharmaceutical professionals and will conclude just before 09:00 am before your first mid-week meetings.  We will be taking feedback during the event about the subjects you would like us to cover in future briefings.

Register here to attend, and feel free to forward the details to your colleagues.

Let’s get 2021 off to a strong start by getting up to speed with the critical issues from our experts’ perspectives.

Key Takeaways

• How changing regulations due to Brexit and the global pandemic may stand to open new doors for innovation and pose new challenges in the industry
• What regulatory guidance is available to help sponsors with the conduct of complex clinical trials
• How we will continue to use virtual technologies to engage with customers
• How we will develop (and redevelop) digital materials in the aftermath of COVID-19.

Agenda

08:00 – 08:10 – Welcome and Introductions ( Dr Malcolm Barratt-Johnson)
08:10 – 08:25 – Post-covid trends shaping medical affairs and clinical development ( Dr Lucy Cook)
08:25 – 08:40 – Supporting innovation through regulatory affairs in 2021 ( Dr Zubair Hussain)
08:40 – 08:55 – Q&A session ( Dr Malcolm Barratt-Johnson)

Click here to register your attendance

About the speakers:

Dr Malcolm Barratt-Johnson

Malcolm is the Managing Director of PharmaMedic and its Senior Consultant.  He has over 18 years of experience as a UK / European based Consultant Pharmaceutical Physician to Industry and Government, specialising in Medical Affairs, Product Development and Regulatory Strategy.

He has acted as a Clinical Specialist and Chair to the European Commission’s Biomedical Research Programme (Horizon 2020), and is a lecturer in medicinal development at King’s College London.

Dr Lucy Cook

Lucy is a Pharmaceutical Physician and company director.  She works chiefly in Medical Affairs on prescription-only medicines but has a keen interest in self-care medicines and medical devices.  Since 2016 Lucy has been Director at Wiltshire Pharma Ltd.  For further information click here.

Dr Zubair Hussain

Dr Zubair Hussain has over 25 years’ experience in Regulatory Affairs, Quality Assurance and Compliance.  His experience includes senior positions in small and large pharmaceutical and medical device companies, with global responsibilities for the EU, US, China, Russia, Asia and Latin America.  His most recent corporate role was at Ipsen Biopharma where Zubair held a global position as Senior Vice President, Global Head of Regulatory Affairs.

Zubair has also previously held the position of President for the TOPRA board, the trade association for professionals in regulatory affairs.  Since 2016, Zubair has been chairman of LE4D Global Regulatory Science, providing innovative regulatory and clinical strategies to the healthcare industry. For further information – https://www.le4d.co.uk/